Fig. 3

Glycerophospholipid metabolism could affect the endogenous lipids in platin-resistant GC patients. A Volcano map showed the differential lipids (VIP > 1.5 and P < 0.05 and fold change > 1.5 or < 0.67). B Cluster heat map of differential lipids in chemotherapy sensitivity and chemotherapy resistance group. C Lipid metabolic pathway analysis based on significantly differential lipids in chemotherapy sensitivity versus chemotherapy resistance groups